Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 17/20 | 0.81 |
| ▸ | CA1 | P00915 | 3/20 | 0.78 |
| ▸ | CA4 | P22748 | 3/20 | 0.78 |
| ▸ | CA12 | O43570 | 2/20 | 0.78 |
| ▸ | CA6 | P23280 | 2/20 | 0.78 |
| ▸ | CA5A | P35218 | 2/20 | 0.78 |
| ▸ | CA7 | P43166 | 2/20 | 0.78 |
| ▸ | CA9 | Q16790 | 2/20 | 0.78 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.78 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.78 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.78 |
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | CA3 | P07451 | 1/20 | 0.60 |
| ▸ | AR | P10275 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7507066 | 1.00 | CA2 (0.81) | CA2CA1CA4CA12CA6 | |
| Hydrochloric Acid SCHEMBL7508036 | 0.99 | CA2 (0.79) | CA2CA1CA4CA12CA6 | |
| SCHEMBL9094182 | 0.91 | CA2 (0.88) | CA2CA1CA4CA12CA6 | |
| Hydrochloric Acid SCHEMBL8870753 | 0.91 | CA2 (0.68) | CA2CA1CA4CA12CA6 | |
| Hydrochloric Acid SCHEMBL9597720 | 0.90 | CA2 (0.86) | CA2CA1CA4CA12CA6 | |
| SCHEMBL9096265 | 0.90 | CA2 (0.83) | CA2CA1CA4CA12CA6 | |
| Hydrochloric Acid SCHEMBL7512923 | 0.90 | CA2 (0.76) | CA2CA1CA4CA12CA6 | |
| SCHEMBL7505749 | 0.89 | CA2 (0.89) | CA2CA1CA4CA12CA6 | |
| SCHEMBL14042262 | 0.89 | CA2 (0.81) | CA2CA1CA4CA12CA6 | |
| SCHEMBL678201 | 0.89 | CA2 (0.75) | CA2CA1CA4CA12CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080108574-A1 | MELANOCORTIN RECEPTOR MEDIATED MODULATION OF NEUROGENESIS | BRAINCELLS, INC. (US) | 2008-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108574-A1 | MELANOCORTIN RECEPTOR MEDIATED MODULATION OF NEUROGENESIS | MC1R, MC3R, MC5R | CA2 3082/4885CA1 2618/4885CA4 4088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.